查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672961

免疫肿瘤学检测市场（按产品、技术、适应症、应用和地区划分）

Immuno-Oncology Assays Market, By Product, By Technology, By Indication, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球免疫肿瘤检测市场规模估计为 55.5 亿美元，预计到 2032 年将达到 118.2 亿美元，2025 年至 2032 年的复合年增长率为 11.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 55.5亿美元
效能资料 从 2020 年到 2024 年 预测期 2025 至 2032 年
预测期：2025-2032年复合年增长率： 11.40％ 2032 年价值预测 118.2亿美元
数字。 2025年免疫肿瘤学检测市场占有率（按地区）
免疫肿瘤学检测市场-IMG1

免疫肿瘤学检测可用于分析与癌症免疫疗法相关的蛋白质等生物分子的表达。这些检测对于肿瘤分析、治疗策略和免疫疗法开发很有用。评估免疫生物标记的表达可以为癌症免疫相互作用提供重要见解，并且可以指导标靶治疗方法。蛋白质体学、基因组学和多路復用技术等领域的发展促进了高通量免疫肿瘤学检测的发展。这些测量预先存在的抗肿瘤免疫反应和预测治疗结果的能力已成为精准肿瘤学的重要工具。

市场动态：

全球免疫肿瘤学检测市场的成长受到多种因素的推动，例如对标靶癌症治疗的需求不断增长、联合免疫疗法的采用日益增多、製药公司研发投资不断增加以及伴同性诊断测试的可用性不断提高。然而，也存在一些市场限制，例如与免疫肿瘤学测试相关的高成本和此类测试的报销有限。同时，生物标记研究的进步和经济实惠的免疫肿瘤学测试的发展为市场参与者带来了巨大的商机。

本研究的主要特点

  • 本报告对全球免疫肿瘤学检测市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（以十亿美元为单位）和年复合成长率（CAGR%）。
  • 它强调了各个领域的潜在收益成长机会，并说明了该市场的一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球免疫肿瘤学检测市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
  • 主要企业包括 Charles River Laboratories、F. Hoffmann-La Roche Ltd、llumina, Inc.、Agilent Technologies, Inc.、Thermo Fisher Scientific Inc.、Merck KGaA、Invivoscribe, Inc.、QIAGEN、PerkinElmer Inc.、Sartorius AG、Bio-Reid Laborator, Inc. Bioscience、HTG Molecular Diagnostics, Inc.、Axion BioSystems, Inc. 和 BioTherapeutics LLC。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球免疫肿瘤学检测市场迎合了该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过用于分析全球免疫肿瘤学检测市场的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管情景
  • 收购与合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

4. 全球免疫肿瘤学检测市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球免疫肿瘤学检测市场（按产品划分）（十亿美元）

  • 耗材
  • 软体

6. 2020 年至 2032 年全球免疫肿瘤学检测市场（按技术划分）（十亿美元）

  • 免疫检测
  • PCR
  • 下一代种子
  • 流式细胞技术
  • 其他的

7. 全球免疫肿瘤学检测市场，按适应症，2020-2032 年（十亿美元）

  • 大肠直肠癌
  • 肺癌
  • 恶性黑色素瘤
  • 膀胱癌
  • 其他的

8. 全球免疫肿瘤学检测市场，按应用划分，2020-2032 年（十亿美元）

  • 临床诊断
  • 研究与开发

9. 2020 年至 2032 年全球免疫肿瘤学检测市场（按地区划分）（单位：十亿美元）

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第十章 竞争格局

  • 公司简介
    • Charles River Laboratories
    • F. Hoffmann-La Roche Ltd
    • llumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Invivoscribe, Inc.
    • QIAGEN
    • PerkinElmer Inc.
    • Sartorius AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Spatial Biology, Inc.
    • Nexelis
    • Reaction Biology
    • Crown Bioscience
    • HTG Molecular Diagnostics, Inc.
    • Axion BioSystems, Inc
    • BioTherapeutics LLC

第 11 章分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十二章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI2632

Global Immuno-Oncology Assays Market is estimated to be valued at USD 5.55 Bn in 2025 and is expected to reach USD 11.82 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.55 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.40% 2032 Value Projection: USD 11.82 Bn
Figure. Immuno-Oncology Assays Market Share (%), By Region 2025
Immuno-Oncology Assays Market - IMG1

Immuno-oncology assays help analyze the expression of biomolecules like proteins that are relevant for cancer immunotherapies. These assays aid in tumor profiling, treatment strategies, and development of immunotherapies. They help evaluate expression of immune biomarkers, which provides crucial insights into cancer-immune interactions and offers direction for targeted therapies. Advancements in fields like proteomics, genomic analysis, and multiplex technologies have enabled development of high-throughput immuno-oncology assays. Their ability to gauge pre-existing antitumor immune responses and predict treatment outcomes makes them integral tools in precision oncology.

Market Dynamics:

The global immuno-oncology assays market growth is driven by factors such as growing demand for targeted cancer therapies, rising adoption of combinational immunotherapies, increasing R&D investments by pharmaceutical companies, and improving availability of companion diagnostic tests. However, the market faces restraints in terms of high costs associated with immuno-oncology assays and limited reimbursement for such tests. Meanwhile, ongoing research on biomarkers and development of affordable immuno-oncology assays present significant opportunities for market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the global immuno-oncology assays market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global immuno-oncology assays market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this includes Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribe, Inc., QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Bruker Spatial Biology, Inc., Nexelis, Reaction Biology, Crown Bioscience, HTG Molecular Diagnostics, Inc., Axion BioSystems, Inc, and BioTherapeutics LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global immuno-oncology assays market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market

Detailed Segmentation-

  • By Product:
    • Consumables
    • Software
  • By Technology:
    • Immunoassay
    • PCR
    • NGS
    • Fow Cytometry
    • Others
  • By Indication:
    • Colorectal Cancer
    • Lung Cancer
    • Melanoma
    • Bladder Cancer
    • Others
  • By Application:
    • Clinical Diagnostics
    • Research and Development
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Charles River Laboratories
    • Hoffmann-La Roche Ltd
    • llumina, Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Invivoscribe, Inc.
    • QIAGEN
    • PerkinElmer Inc.
    • Sartorius AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Spatial Biology, Inc.
    • Nexelis
    • Reaction Biology
    • Crown Bioscience
    • HTG Molecular Diagnostics, Inc.
    • Axion BioSystems, Inc
    • BioTherapeutics LLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By Indication
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Immuno-Oncology Assays Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Immuno-Oncology Assays Market, By Product, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Software
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Immuno-Oncology Assays Market, By Technology, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Immunoassay
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • PCR
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • NGS
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Fow Cytometry
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Immuno-Oncology Assays Market, By Indication, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Colorectal Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Lung Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Melanoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Bladder Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Immuno-Oncology Assays Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research and Development
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Immuno-Oncology Assays Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Charles River Laboratories*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • llumina, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Invivoscribe, Inc.
    • QIAGEN
    • PerkinElmer Inc.
    • Sartorius AG
    • Bio-Rad Laboratories, Inc.
    • Bruker Spatial Biology, Inc.
    • Nexelis
    • Reaction Biology
    • Crown Bioscience
    • HTG Molecular Diagnostics, Inc.
    • Axion BioSystems, Inc
    • BioTherapeutics LLC

11. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact